JAG1 overexpression in tumors contributes to tumor growth, metastasis, recurrence, and drug resistance by promoting cancer cell survival, proliferation, metastasis, cancer stem cell expansion, and tumor-associated angiogenesis, and by inhibiting tumor-specific immunity [7,8]. The gene discussed is JAG1; the disease is neoplasm.